Evidence map›Paper›PMID 26695843›Full record

ArticleThe Journal of physiology2016

Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

G Mazzocchi, L Sommese, J Palomeque, J I Felice, M N Di Carlo, D Fainstein, P Gonzalez, P Contreras, D Skapura, M D McCauley and 6 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Frontiers in cardiovascular medicine · 2022
    Article
  3. CaPflugers Archiv : European journal of physiology · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. SERCA2a: a key protein in the CaHeart failure reviews · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Unbalance Between Sarcoplasmic Reticulum CaFrontiers in physiology · 2019
    Review
  12. CaAmerican journal of physiology. Heart and circulatory physiology · 2017
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

G MazzocchiCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
L SommeseCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
J PalomequeCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
J I FeliceCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
M N Di CarloCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
D FainsteinCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
P GonzalezCátedra de Patología, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
P ContrerasDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
D SkapuraDepartments of Molecular Physiology and Biophysics, Medicine (in Cardiology), and Pediatrics, Baylor College of Medicine, Cardiovascular Research Institute, Houston, TX, 77030, USA.
M D McCauleyDepartments of Molecular Physiology and Biophysics, Medicine (in Cardiology), and Pediatrics, Baylor College of Medicine, Cardiovascular Research Institute, Houston, TX, 77030, USA.
E C LascanoDepartamento de Biología Comparada, Celular y Molecular, Universidad Favaloro, Ciudad Autónoma de Buenos Aires, Argentina.
J A NegroniDepartamento de Biología Comparada, Celular y Molecular, Universidad Favaloro, Ciudad Autónoma de Buenos Aires, Argentina.
E G KraniasDepartment of Pharmacology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267.
X H T WehrensDepartments of Molecular Physiology and Biophysics, Medicine (in Cardiology), and Pediatrics, Baylor College of Medicine, Cardiovascular Research Institute, Houston, TX, 77030, USA.
C A ValverdeCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
A MattiazziCentro de Investigaciones Cardiovasculares, CCT-La Plata-CONICET, Facultad de Cs Médicas, UNLP, La Plata, Argentina.
Centro de Investigaciones Cardiovasculares · ARBaylor College of Medicine · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARFavaloro University · ARUniversidad Católica de La Plata · ARUniversidad de la República · UYUniversity of Cincinnati Medical Center · US

Funding

Cardiac Sarcoplasmic Reticulum Calcium Cycling ProteinsR01HL064018 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 2000 to 2017
$6.8M
Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
TARGETED ABLATION AND ALTERATION OF MOUSE PHOSPHOLAMBANR01HL026057 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 1985 to 2017
$5.3M
Regulation of Sarcoplasmic Reticulum Calcium Release in Heart FailureR01HL091947 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2009 to 2019
$3.2M
Determining the Role of Junctophilin-2 in Cardiac DiseaseR01HL117641 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2014 to 2017
$2.3M
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillationK08HL130587 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCCAULEY, MARK D · 2016 to 2020
$892k
Development of novel compounds for the treatment of atrial fibrillationR41HL129570 · NHLBI · ELEX BIOTECH, LLC · PI WEHRENS, XANDER H.T. · 2015 to 2015
$428k
NHLBI NIH HHS K08 HL130587NHLBI NIH HHS R01 HL026057NHLBI NIH HHS R01 HL064018NHLBI NIH HHS R01 HL089598NHLBI NIH HHS R01 HL091947NHLBI NIH HHS R01 HL117641NHLBI NIH HHS R41 HL129570
6 · The paper itself

Abstract

key pointsMice with Ca(2+) -calmodulin-dependent protein kinase (CaMKII) constitutive pseudo-phosphorylation of the ryanodine receptor RyR2 at Ser2814 (S2814D(+/+) mice) exhibit a higher open probability of RyR2, higher sarcoplasmic reticulum (SR) Ca(2+) leak in diastole and increased propensity to arrhythmias under stress conditions. We generated phospholamban (PLN)-deficient S2814D(+/+) knock-in mice by crossing two colonies, S2814D(+/+) and PLNKO mice, to test the hypothesis that PLN ablation can prevent the propensity to arrhythmias of S2814D(+/+) mice. PLN ablation partially rescues the altered intracellular Ca(2+) dynamics of S2814D(+/+) hearts and myocytes, but enhances SR Ca(2+) sparks and leak on confocal microscopy. PLN ablation diminishes ventricular arrhythmias promoted by CaMKII phosphorylation of S2814 on RyR2. PLN ablation aborts the arrhythmogenic SR Ca(2+) waves of S2814D(+/+) and transforms them into non-propagating events. A mathematical human myocyte model replicates these results and predicts the increase in SR Ca(2+) uptake required to prevent the arrhythmias induced by a CaMKII-dependent leaky RyR2. ABSTRACT: Mice with constitutive pseudo-phosphorylation at Ser2814-RyR2 (S2814D(+/+) ) have increased propensity to arrhythmias under β-adrenergic stress conditions. Although abnormal Ca(2+) release from the sarcoplasmic reticulum (SR) has been linked to arrhythmogenesis, the role played by SR Ca(2+) uptake remains controversial. We tested the hypothesis that an increase in SR Ca(2+) uptake is able to rescue the increased arrhythmia propensity of S2814D(+/+) mice. We generated phospholamban (PLN)-deficient/S2814D(+/+) knock-in mice by crossing two colonies, S2814D(+/+) and PLNKO mice (SD(+/+) /KO). SD(+/+) /KO myocytes exhibited both increased SR Ca(2+) uptake seen in PLN knock-out (PLNKO) myocytes and diminished SR Ca(2+) load (relative to PLNKO), a characteristic of S2814D(+/+) myocytes. Ventricular arrhythmias evoked by catecholaminergic challenge (caffeine/adrenaline) in S2814D(+/+) mice in vivo or programmed electric stimulation and high extracellular Ca(2+) in S2814D(+) /(-) hearts ex vivo were significantly diminished by PLN ablation. At the myocyte level, PLN ablation converted the arrhythmogenic Ca(2+) waves evoked by high extracellular Ca(2+) provocation in S2814D(+/+) mice into non-propagated Ca(2+) mini-waves on confocal microscopy. Myocyte Ca(2+) waves, typical of S2814D(+/+) mice, could be evoked in SD(+/+) /KO cells by partially inhibiting SERCA2a. A mathematical human myocyte model replicated these results and allowed for predicting the increase in SR Ca(2+) uptake required to prevent the arrhythmias induced by a Ca(2+) -calmodulin-dependent protein kinase (CaMKII)-dependent leaky RyR2. Our results demonstrate that increasing SR Ca(2+) uptake by PLN ablation can prevent the arrhythmic events triggered by SR Ca(2+) leak due to CaMKII-dependent phosphorylation of the RyR2-S2814 site and underscore the benefits of increasing SERCA2a activity on SR Ca(2+) -triggered arrhythmias.

Indexed as

Action PotentialsAnimalsArrhythmias, CardiacCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Gene Knock-In TechniquesMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyocytes, CardiacPhospholambanPhosphorylationRyanodine Receptor Calcium Release ChannelCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Phospholambanryanodine receptor 2. mouseRyanodine Receptor Calcium Release Channel

Identifiers

PMID26695843
PMCPMC4887664
OpenAlexW2253258982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.